Results 201 to 210 of about 29,638 (318)
Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease
T. A. MIETTINEN1, T. Miettinen
semanticscholar +1 more source
Abstract The mood stabilizers lithium and valproate are psychotropic medications widely used in clinical practice. Despite their proven benefits, many individuals stop their treatment due to the adverse effects. Chronic diarrhoea is a common reason for discontinuation of these drugs; however, the underlying mechanisms are unknown.
Sofia Cussotto+10 more
wiley +1 more source
7β-Hydroxysteroid dehydratase Hsh3 eliminates the 7-hydroxy group of the bile salt ursodeoxycholate during degradation by <i>Sphingobium</i> sp. strain Chol11 and other <i>Sphingomonadaceae</i>. [PDF]
Richtsmeier P+10 more
europepmc +1 more source
Bile Salts Deconjugation Using Microencapsulated Lactic Acid Bacteria Isolated from Handmade Yogurt [PDF]
Gülçin Alp Avcı
openalex +1 more source
Bile acids and colonic motility in the rabbit and the human.
W. Kirwan+4 more
semanticscholar +1 more source
ABSTRACT Acute kidney injury is a common complication in patients undergoing orthotopic liver transplantation, being associated with increased mortality and prolonged hospitalization. This study aimed to develop a novel analytical strategy for the early diagnosis of acute kidney injury in liver transplant recipients by combining an untargeted ...
Larissa C. Motta+13 more
wiley +1 more source
Murine norovirus allosteric escape mutants mimic gut activation. [PDF]
Sherman MB+6 more
europepmc +1 more source
ABSTRACT The enzyme glycine N‐acyltransferase (GLYAT) plays a crucial role in detoxifying both xenobiotic and endogenous compounds that contain a carboxylic acid group, such as benzoic acid. Data on the impact of human GLYAT on the glycine conjugation pathway is limited and difficult to determine.
Mona Nourbakhsh+13 more
wiley +1 more source
Gallstones after bariatric surgery: mechanisms and prophylaxis. [PDF]
Chen S, Zheng Y, Cai J, Wu Y, Chen X.
europepmc +1 more source
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi+5 more
wiley +1 more source